DiscoverBlood Cancer TalksEpisode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman
Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman

Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman

Update: 2023-12-271
Share

Description

In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode: 

First, we will focus on a few abstracts in precursor states, MGUS. 

1.      New diagnostic criteria for light chain MGUS (IStopMM): 

             https://ash.confex.com/ash/2023/webprogram/Paper188547.html

             https://ash.confex.com/ash/2023/webprogram/Paper182661.html


2.     PERSEUS Trial-Dara-VRD vs VRD in newly diagnosed transplant-eligible myeloma: 

https://ash.confex.com/ash/2023/webprogram/Paper191911.html

 

3.     ISKIA trial: Isa-KRD vs KRD in newly diagnosed transplant-eligible myeloma:

 https://ash.confex.com/ash/2023/webprogram/Paper177546.html

 

4.     Phase 1/2 study for Daratumumab-Venetoclax-Dexamethasone in early relapsed t(11;14) myeloma:

 

https://ash.confex.com/ash/2023/webprogram/Paper180766.html

 

5.     GMMG Relapse Trial (Long-term follow-up data from randomized controlled trial of salvage transplant in myeloma)

 
https://ash.confex.com/ash/2023/webprogram/Paper178835.html

 

6.     Overall survival results of KarMMa-3 trial

 

https://ash.confex.com/ash/2023/webprogram/Paper178933.html

 

7.      GEM2017FIT Trial: Dara-KRd vs KRd vs VMP-RD in non-transplant eligible patients:

 

https://ash.confex.com/ash/2023/webprogram/Paper179866.html

 

 

 

 

 

 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman

Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman

Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff